2. Neumora KOASTAL-2 Research Study for Adults with MDD

Neumora KOASTAL-2 Research Study for Adults with MDD

Principal Investigator

Joao L. De Quevedo, MD, PhD

Overview:

This study, led by Nurmora, aims to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days) and a 6-week Treatment Period (during which participants will receive either NMRA-335140 or a placebo).

Inclusion Criteria:

  • Be 18 to 65 years of age.
  • Meet DSM-5 diagnostic criteria for recurrent or single-episode MDD without psychotic features.
  • The symptoms of the current MDD episode have been present for more than 4 weeks but no longer than 12 months.
  • Additional criteria will apply.

What you may be asked to do:

  • Office visits.
  • Completing surveys.
  • Blood samples.
  • Completing a medication diary.

What You May Get:

You may be compensated on a per-visit basis.

Location:

Interventional Psychiatry Clinic

7000 Fannin Street, Suite 1620

Houston, TX, 77030

Contact:

Email: [email protected]

Phone: (713) 486-2567

Take the study survey here (external link) 

ClinicalTrials.gov ID: NCT06058013 (external link) (https://clinicaltrials.gov/study/NCT06058013)